《大行報告》花旗:汽車股今年首選小鵬-W(09868.HK)、吉利(00175.HK)及中升(00881.HK)
花旗發表報告指,今年內地汽車製造業前景主要涉及三方面,包括1月的銷售上升、內燃機(ICE)轉勢,及第二季和第三季的風險逆轉。
該行預期,今年初新能源車的表現會跑贏,首兩個月料有強勁銷售,對比同業,預期小鵬汽車(09868.HK)將有最好的上升空間。另外,中期而言,在內燃機乘用車銷量前景按年有改善下,估計經銷商會追落後。
中資汽車股中,花旗今年首選為小鵬汽車、吉利汽車(00175.HK)及中升控股(00881.HK)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.